Orphazyme kicks off Dkr675m IPO in Copenhagen with anchor backing
Dagmar Richardt - stock.adobe.com
Orphazyme, a Danish biotechnology company, has revealed the terms for its IPO on Nasdaq Copenhagen.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: